MEETINGS & COURSES
Find a meeting

 FEATURED MEETINGS
  Rome 2010
  Kiawah Eye 2010
  OSN New York 2010
  Hawaiian Eye 2011
  Retina 2011
 
Breaking Influenza
A (H1N1) Updates
OCULAR SURGERY NEWS U.S. EDITION November 25, 2009
Studying biological, environmental risk factors 'next step' in determining genetic role in pseudoexfoliation risk
Submit a Comment Submit a Comment Print  Print Email this page to a friend  E-mail

SAN FRANCISCO — More research is needed to determine the impact that genetics and other risk factors have on the progression of pseudoexfoliation syndrome, a clinician said here.

"So what are the next steps that we have to do in looking at how a patient progresses from early disease to end stage disease?" Sayoko E. Moroi, MD, PhD, asked at the Glaucoma Subspecialty Day prior to the American Academy of Ophthalmology meeting. "We have to look at all these biological risk factors ... [and] the environmental risks [are] something clearly we're just beginning to begin to understand in glaucoma."

Biological risk factors that should be further studied are aging, oxidative stress, ocular manifestations versus systemic manifestations and individual genetic risk alles, Dr. Moroi said.

Environmental risk factors that could impact disease progression and treatment response include smoking, diet, medications and infections, she said.

PERSPECTIVE

It is largely unknown why some patients with pseudoexfoliation have an indolent course and why others have an aggressive disease. Dr. Moroi has identified several areas to pursue. Current techniques in molecular biology, genetics and epidemiology have become powerful enough for us to begin to uncover the relative contributions of some of these potential risk factors.

– Douglas J. Rhee, MD
OSN Glaucoma Board Member

The OSN SuperSite is intended for physician use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will the OSN SuperSite be used for medical advice to patients.

There are no comments for this article. Be the first to comment.

Your comment

Name:
Comments:
SEE ALSO
From the AAO meeting to my operating room
Posted on the OSN SuperSite November 6, 2009
iScience Interventional introduces micro-aspiration retinal cannula
Posted on the OSN SuperSite November 3, 2009
Moria announces launch of single-use surgical instruments
Posted on the OSN SuperSite November 3, 2009
Ozurdex injection technique
Ozurdex injection technique

Submitted by: Allergan; Sunil Gupta, MD (2/4/2010).

Endothelial keratoplasty challenges the primacy of full-thickness transplantation
Corneal transplantation has long been the preferred treatment for pathologies that respond poorly to topical medications or implants.